Compounds > 1,2-bis(3,5-dioxopiperazin-1-yl)ethane
Page last updated: 2024-08-25

1,2-bis(3,5-dioxopiperazin-1-yl)ethane and Heart Diseases

1,2-bis(3,5-dioxopiperazin-1-yl)ethane has been researched along with Heart Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grossmann, V; Kvĕtina, J; Safárová, M; Svoboda, Z1

Other Studies

1 other study(ies) available for 1,2-bis(3,5-dioxopiperazin-1-yl)ethane and Heart Diseases

ArticleYear
Preclinical comparison of bis-diketopiperazine-propane (dexrazoxane) and bis-diketopiperazine-ethane (antimet) on the adriamycin-cardiotoxic effect.
    Neoplasma, 1997, Volume: 44, Issue:2

    Topics: Administration, Oral; Animals; Cardiovascular Agents; Doxorubicin; Drug Evaluation, Preclinical; Electroencephalography; Female; Heart Diseases; Myometrium; Piperazines; Rats; Rats, Wistar; Razoxane

1997